How do you decide when data patients bring to you for review/interpretation from a direct-to-consumer CGM is clinically useful and has it changed any of your management decisions in metabolically at-risk patients?

This is a tough question, as there is obviously published data for FDA-approved CGM devices, as published below:

CGM Device Comparison | American Association of Clinical Endocrinology

However, for those provided by independent companies, it would depend on whether or not they have independent third-...